1. (a) In this subtitle the following words have the meanings indicated.
2. (b) “Board” means the State Board of Pharmacy.

3. (c) “Dispense” means to provide:

   1. (1) A prescription drug or medical supply in accordance with a prescription; or
   2. (2) An over-the-counter drug or medical supply.

4. (d) “Drop-off site” means a pharmacy, other health care facility, or other entity participating in a drug donation or repository program and designated by the Board that:

   1. (1) Has voluntarily agreed to accept donated prescription drugs, over-the-counter drugs, or medical supplies;
   2. (2) Is located within the State or in another state; and
   3. (3) Does not have a final disciplinary order issued against it by a health occupations board.
5. (e) “Eligible patient” means an individual who, through self-attestation, is indigent, uninsured, underinsured, or enrolled in a public health benefits program.
6. (f) “Program” means the Prescription Drug Repository Program.

7. (g) “Repository” means a licensed pharmacy that:

   1. (1) If the licensed pharmacy is located in the State, does not have a final disciplinary order issued against it by the Board of Pharmacy;
   2. (2) Has voluntarily agreed to participate in the Program;
   3. (3) Is located in the State or in another state; and

   4. (4) Has been approved by the Board to:

      1. (i) Accept donated prescription drugs, over-the-counter drugs, or medical supplies from a designated drop-off site;
      2. (ii) Dispense the donated prescription drugs, over-the-counter drugs, or medical supplies to eligible patients; or
      3. (iii) Dispose of prescription drugs, over-the-counter drugs, or medical supplies not accepted for dispensing to eligible patients.

8. (h) “Tamper-evident packaging” means a packaging system that:

   1. (1) May involve an immediate-container and closure system, secondary-container or carton system, tertiary-container system, or other combination of systems intended to provide a visual indication of package integrity;
   2. (2) May contain unit-dose or multi-dose contents; and

   3. (3) Has one or more indicators or barriers to entry that:

      1. (i) If breached or missing, can reasonably be expected to provide visible evidence to consumers that tampering has occurred; and
      2. (ii) If handled in a reasonable manner during manufacture, distribution, or retail display, is designed to remain intact.

Added by Acts 2006, c. 287, § 1, eff. July 1, 2006. Amended by Acts 2011, c. 546, § 1, eff. Oct. 1, 2011; Acts 2011, c. 547, § 1, eff. Oct. 1, 2011; Acts 2024, c. 376, § 1, eff. Oct. 1, 2024; Acts 2025, c. 705, § 1, eff. Oct. 1, 2025.